Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 7, 2012, Pages 1222-1225

  Mondul, Alison M ^a   Weinstein, Stephanie J ^a   Horst, Ronald L ^c   Purdue, Mark ^b   Albanes, Demetrius ^a  

^a Nutritional Epidemiology Branch   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Heartland Assays Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D BINDING PROTEIN;

ADULT; AGE; AGED; ARTICLE; BLADDER CANCER; BLOOD SAMPLING; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RACE; SEX; STATISTICAL SIGNIFICANCE; VITAMIN BLOOD LEVEL;

AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 84863596031     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0439     Document Type: Article

References (7)

1. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review. Cancer Causes Control 2005;16:83-95. (Pubitemid 40691207)
2. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004;79:362-71. (Pubitemid 41115577)
3. Helzlsouer KJ. Overview of the Cohort Consortium Vitamin D Pooling Project of rarer cancers. Am J Epidemiol 2010;172:4-9.
4. Mondul AM, Weinstein SJ, Mannisto S, Snyder K, Horst RL, Virtamo J, et al. Serum vitamin D and risk of bladder cancer. Cancer Res 2010;70:9218-23.
5. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening trial. Control Clin Trials 2000;21:273S-309S.
6. Gallicchio L, Helzlsouer KJ, Chow WH, Freedman DM, Hankinson SE, Hartge P, et al. Circulating 25-hydroxyvitamin D and the risk of rarer cancers: design and methods of the Cohort Consortium Vitamin D Pooling Project of rarer cancers. Am J Epidemiol 2010;172:10-20.
7. Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW, Silverman DT. Serum vitamin D and risk of pancreatic cancer in the Prostate, Lung, Colorectal, and Ovarian Screening trial. Cancer Res 2009;69:1439-47.